뇌졸중 이후의 이상지혈증의 관리 = Management of Dyslipidemia after Stroke

다국어 초록 (Multilingual Abstract)

Dyslipidemia is a major risk factor for stroke, following hypertension, diabetes, and smoking. Treatment of dyslipidemia is important for the prevention and treatment of various vascular diseases, including stroke, coronary artery disease, and peripheral vascular disease. Statins, ezetimibe, and proprotein convertase subtilisinkexin type 9 (PCSK9) inhibitors have been shown to reduce the risk of stroke and cardiovascular disease in previous studies. When prescribing dyslipidemia drugs for secondary prevention of stroke, the combination, type, and dose of dyslipidemia drugs should be appropriately selected according to the patient's comorbidity and stroke subtype. In the case of statins, highintensity statin administration should be considered, but it is essential to take into account side effects, comorbidities, and individual characteristics of each patient.
If the target low density lipoproteincholesterol level is not reached or inappropriate drug dosing due to the side effects of statins, ezetimibe or a PCSK9 inhibitor may be considered. Finally, statin discontinuation due to improper judgment may be detrimental to the patient in the longterm view.

참고문헌 (Reference)

1 Ference BA, "Variation in PCSK9 and HMGCR and risk of car-diovascular disease and diabetes" 375 : 2144-2153, 2016

2 Ganda OP, "Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management" 72 : 330-343, 2018

3 Fang WT, "The role of statin therapy in the pre-vention of atrial fibrillation : a meta-analysis of randomized controlled trials" 74 : 744-756, 2012

4 Hanger HC, "The risk of recurrent stroke after intracerebral haemorrhage" 78 : 836-840, 2007

5 Wilson PWF, "Systematic review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol : a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines" 139 : e1144-e1161, 2019

6 Shah RV, "Statins and risk of new-onset diabetes mellitus" 126 : e282-e284, 2012

7 Hackam DG, "Statins and intracerebral hemorrhage : collaborative systematic review and meta-analysis" 124 : 2233-2242, 2011

8 Goldstein LB, "Statins after intracerebral hemorrhage : to treat or not to treat" 68 : 565-566, 2011

9 Selva-O’Callaghan A, "Statin-induced myal-gia and myositis : an update on pathogenesis and clinical recommend-ations" 14 : 215-224, 2018

10 Tomaszewski M, "Statin-in-duced myopathies" 63 : 859-866, 2011

11 Milionis H, "Statin-based therapy for primary and secondary prevention of ischemic stroke : a meta-analysis and critical overview" 15 : 377-384, 2020

12 Westover MB, "Statin use following intracerebral hemorrhage : a decision analysis" 68 : 573-579, 2011

13 McKinney JS, "Statin therapy and the risk of intracerebral hemorrhage : a meta-analysis of 31 randomized controlled trials" 43 : 2149-2156, 2012

14 Park HK, "Statin ther-apy in acute cardioembolic stroke with no guidance-based indication" 94 : e1984-e1995, 2020

15 Newman CB, "Statin safety and associated adverse events : a scientific state-ment from the American Heart Association" 39 : e38-e81, 2019

16 Flint AC, "Statin ad-herence is associated with reduced recurrent stroke risk in patients with or without atrial fibrillation" 48 : 1788-1794, 2017

17 Hindy G, "Role of blood lipids in the development of ischemic stroke and its subtypes : a Mendelian randomization study" 49 : 820-827, 2018

18 Amarenco P, "Results of the stroke prevention by aggressive re-duction in cholesterol levels(SPARCL)trial by stroke subtypes" 40 : 1405-1409, 2009

19 Varbo A, "Remnant cholesterol and risk of ischemic stroke in 112, 512 individuals from the general population" 85 : 550-559, 2019

20 Qi Z, "Relation of low-den-sity lipoprotein cholesterol to ischemic stroke in patients with non-valvular atrial fibrillation" 119 : 1224-1228, 2017

21 Bailey RD, "Recurrent brain hemor-rhage is more frequent than ischemic stroke after intracranial hemor-rhage" 56 : 773-777, 2001

22 Bohula EA, "Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT(improved reduction of outcomes : vytorin efficacy international trial)" 136 : 2440-2450, 2017

23 Oesterle A, "Pleiotropic effects of statins on the car-diovascular system" 120 : 229-243, 2017

24 Liao JK, "Pleiotropic effects of statins" 45 : 89-118, 2005

25 Burnett JR, "PCSK9-a journey to cardiovascular outcomes" 379 : 2161-2162, 2018

26 Chaudhary R, "PCSK9 inhibitors : a new era of lipid lowering therapy" 9 : 76-91, 2017

27 Dullaart RPF, "PCSK9 inhibition to reduce cardiovascular events" 376 : 1790-1791, 2017

28 Amarenco P, "One-year risk of stroke after transient ischemic attack or minor stroke" 374 : 1533-1542, 2016

29 Navarese EP, "Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus" 111 : 1123-1130, 2013

30 Poon MT, "Long-term prognosis after intracerebral haemorrhage : systematic review and meta-analysis" 85 : 660-667, 2014

31 Amarenco P, "Lipid management in the prevention of stroke : review and updated meta-analysis of statins for stroke prevention" 8 : 453-463, 2009

32 Kurth T, "Lipid levels and the risk of ischemic stroke in women" 68 : 556-562, 2007

33 Cannon CP, "Intensive versus moderate lipid lowering with statins after acute coronary syndromes" 350 : 1495-1504, 2004

34 Jepsen AM, "Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease" 62 : 593-604, 2016

35 Nichols GA, "Increased cardiovascular risk in hypertriglyceridemic patients with statin-con-trolled LDL cholesterol" 103 : 3019-3027, 2018

36 Amarenco P, "High-dose atorvastatin after stroke or transient ischemic attack" 355 : 549-559, 2006

37 Goldstein LB, "Hemorrhagic stroke in the stroke prevention by ag-gressive reduction in cholesterol levels study" 70 : 2364-2370, 2008

38 Benjamin EJ, "Heart disease and stroke statistics-2019 update : a re-port from the American Heart Association" 139 : e56-e528, 2019

39 Meschia JF, "Guidelines for the primary prevention of stroke : a statement for healthcare professionals from the American Heart Association/American Stroke Association" 45 : 3754-3832, 2014

40 Kernan WN, "Guidelines for the prevention of stroke in pa-tients with stroke and transient ischemic attack : a guideline for health-care professionals from the American Heart Association/American Stroke Association" 45 : 2160-2236, 2014

41 Amarenco P, "Five-year risk of stroke after TIA or minor ische-mic stroke" 378 : 2182-2190, 2018

42 Casolla B, "Five-year risk of major ischemic and hemorrhagic events after intra-cerebral hemorrhage" 50 : 1100-1107, 2019

43 Cannon CP, "Ezetimibe added to statin therapy after acute coronary syndromes" 372 : 2387-2397, 2015

44 Hammersley D, "Ezetimibe : an update on its clinical useful-ness in specific patient groups" 8 : 4-11, 2017

45 Sabatine MS, "Evolocumab and clinical outcomes in patients with cardiovascular disease" 376 : 1713-1722, 2017

46 Cholesterol Treatment Trialists’ Collaboration, "Efficacy and safety of statin therapy in older people : a meta-analysis of individual partic-ipant data from 28 randomised controlled trials" 393 : 407-415, 2019

47 Baigent C, "Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170, 000 participants in 26 randomised trials" 376 : 1670-1681, 2010

48 Simsek S, "Effects of rosuvastatin and atorvastatin on glycaemic control in type 2 diabetes---the CORALL study" 29 : 628-631, 2012

49 Collins R, "Effects of cholester-ol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions" 363 : 757-767, 2004

50 Sukhija R, "Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients" 57 : 495-499, 2009

51 Flint AC, "Effect of statin use during hospitalization for intracerebral hemor-rhage on mortality and discharge disposition" 71 : 1364-1371, 2014

52 Choi KH, "Effect of statin therapy on outcomes of patients with acute ischemic stroke and atrial fibrillation" 8 : e013941-, 2019

53 Reeves MJ, "Effect of pretreatment with statins on ischemic stroke outcomes" 39 : 1779-1785, 2008

54 Choi JC, "Effect of pre-stroke statin use on stroke severity and early functional recovery : a retrospective cohort study" 15 : 120-, 2015

55 허지회 ; 송동범 ; 남효석 ; 김응엽 ; 김영대 ; 이경열 ; 이기정 ; 유준상 ; 김윤남 ; 이병철 ; 윤병우 ; Jong S. Kim, "Effect and Safety of Rosuvastatin in Acute Ischemic Stroke" 대한뇌졸중학회 18 (18): 87-95, 2016

56 Kang J, "Early statin use in ischemic stroke patients treated with recanalization therapy : retro-spective observational study" 15 : 122-, 2015

57 정한길 ; 김범준 ; 양미화 ; 한문구 ; 배희준, "Early Statins after Intravenous or Endovascular Recanalization Is Beneficial Regardless of Timing, Intensity, and Stroke Mechanism" 대한뇌졸중학회 19 (19): 370-372, 2017

58 Goh SL, "Does preoperative statin therapy prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?" 20 : 422-428, 2015

59 Ornello R, "Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes : a systematic review and meta-analysis" 49 : 814-819, 2018

60 Baker WL, "Differing effect of statins on insulin sensitivity in non-diabetics : a systematic review and meta-analysis" 87 : 98-107, 2010

61 Vangen-Lønne AM, "Declining incidence of ischemic stroke: what is the im-pact of changing risk factors? The Tromsø study 1995 to 2012" 48 : 544-550, 2017

62 Su L, "Current management guidelines on hyperlipidemia : the silent killer" 2021 : 9883352-, 2021

63 Saver JL, "Cryptogenic stroke" 375 : e26-, 2016

64 Tapia-Pérez JH, "Continued statin therapy could improve the outcome after sponta-neous intracerebral hemorrhage" 36 : 279-287, 2013

65 Tramacere I, "Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack : a systematic review and network meta-analysis" 17 : 67-, 2019

66 Yebyo HG, "Comparative ef-fectiveness and safety of statins as a class and of specific statins for pri-mary prevention of cardiovascular disease : a systematic review, meta-analysis, and network meta-analysis of randomized trials with 94, 283 participants" 210 : 18-28, 2019

67 Montaner J, "Combination of thrombolysis and statins in acute stroke is safe : results of the STARS randomized trial(stroke treat-ment with acute reperfusion and simvastatin)" 47 : 2870-2873, 2016

68 Davignon J, "Beneficial cardiovascular pleiotropic effects of statins" 109 : III39-III43, 2004

69 Cai T, "Associations between statins and adverse events in primary prevention of cardiovascular disease : systematic review with pairwise, network, and dose-response meta-analyses" 374 : n1537-, 2021

70 Malhotra K, "Association of statin pretreatment with collateral circulation and final infarct volume in acute ischemic stroke patients : a meta-analysis" 282 : 75-79, 2019

71 Fauchier L, "Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials" 51 : 828-835, 2008

72 Schwartz GG, "Alirocumab and cardiovascular outcomes after acute coronary syndrome" 379 : 2097-2107, 2018

73 Mach F, "Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, hae-morrhagic stroke and cataract" 39 : 2526-2539, 2018

74 Amarenco P, "A comparison of two LDL cholesterol targets after ischemic stroke" 382 : 9-, 2019

75 Mach F, "2019 ESC/EAS guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk" 41 : 111-188, 2020

76 Arnett DK, "2019 ACC/AHA guideline on the primary prevention of cardiovascular disease : a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines" 140 : e596-e646, 2019

77 Powers WJ, "2018 guidelines for the early management of patients with acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 49 : e46-e110, 2018

78 이은정 ; 김현창 ; 김재현 ; 이은영 ; 김병진 ; 김은미 ; 송윤주 ; 임정현 ; 김해진 ; 최성훈 ; 문민경 ; 나진오 ; 박광열 ; 오미선 ; 한상엽 ; 노정현 ; 이경희 ; 이상학 ; 홍순철 ; 정인경, "2018 Guidelines for the management of dyslipidemia" 대한내과학회 34 (34): 723-771, 2019

79 Grundy SM, "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholester-ol : a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines" 139 : e1082-e1143, 2019